You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
輝瑞(PFE.US):新冠肺炎不會在未來幾年內消失 有必要注射第四針
阿思達克 03-15 15:53
美國藥廠輝瑞(PFE.US)行政總裁布爾拉日前於《Face the Nation》中預期,新冠肺炎不會在未來幾年內消失,因此應學習與病毒共存。 他又透露,正努力製造一種可以預防包括Omicron在內的所有變體的疫苗,並要製造至少可以保護一年的疫苗,如能做到這點,才能真正可回到過去的生活方式。 此外,他認爲按照目前情況,完全接種了疫苗的人有必要在今年晚些時候注射第四針,亦即是第二劑加強針,因爲人們可從第三針中得到足夠保護,實際上對降低住院率和死亡率非常有效,但預防感染效果並不是太好,因不能持續很長時間。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account